Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Universal pneumococcal 7-valent vaccination cost effective

    • 11 Accesses

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Bergman A, Hjelmgren J, Örtqvist Å, Wisløff T, Sønbø Kristiansen I, Diaz Högberg L, Persson K M-S, Persson U.Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden. Scandinavian Journal of Infectious Diseases 40: 721-729, No. 9, 2008

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Universal pneumococcal 7-valent vaccination cost effective. Pharmacoecon. Outcomes News 565, 1 (2008). https://doi.org/10.2165/00151234-200805650-00001

    Download citation

    Keywords

    • Acute Otitis Medium
    • Pneumococcal Meningitis
    • Herd Immunity
    • Swedish Krona
    • Incremental QALYs